The Journal of Immunology, Vol 141, Issue 1 99-104, Copyright © 1988 by American Association of Immunologists

ARTICLES

Spontaneous cytotoxicity and tumor necrosis factor production by peripheral blood monocytes from AIDS patients

SC Wright, A Jewett, R Mitsuyasu and B Bonavida
Department of Microbiology and Immunology, UCLA School of Medicine, Los Angeles, CA 90024.

Peripheral blood monocytes (PBM) from AIDS patients have exhibited defects in some but not all of the immune functions yet tested. This study has examined the capacity of AIDS PBM to lyse tumor target cells as well as their ability to secrete TNF. Untreated PBM from AIDS patients were significantly cytotoxic to U937 target cells and responded to IFN-gamma pretreatment with augmented cytotoxicity. Both the spontaneous and IFN-gamma-stimulated cytotoxic activity was significantly (p less than 0.01) higher than that observed with normal PBM. The cytotoxic activity depended on the E:T ratio used and was higher in AIDS PBM at all ratios tested (10:1 to 40:1). Because TNF has been implicated in macrophage cell-mediated cytotoxicity, we examined whether the elevated cytotoxic activity of AIDS PBM was associated with an increase in TNF production. Supernatants from PBM cultured overnight with or without IFN-gamma were tested in a bioassay measuring cytotoxicity against U937 target cells as well as in an RIA specific for TNF. Supernatants derived from either unstimulated or IFN-gamma- treated AIDS PBM exhibited significantly higher levels of cytotoxicity than supernatants from normal macrophages. Both normal and AIDS PBM produced higher levels of cytotoxic factors in response to IFN-gamma. As determined by the RIA, AIDS PBM spontaneously released high levels of TNF whereas little TNF was produced by normal PBM. Treatment with IFN-gamma augmented the level of TNF production in both AIDS and normal PBM. These results demonstrate that PBM from AIDS patients have undergone in vivo activation as manifested by both cytotoxicity against tumor target cells and production of TNF. Target cell lysis by both AIDS PBM and their supernatants was inhibited by monoclonal anti-rTNF, suggesting that the increase in PBM cell-mediated cytotoxicity was caused by an increase in TNF production. The significance of these findings in the pathogenesis of the disease is discussed.

This article has been cited by other articles:

				J. M. Beck The Immunocompromised Host: HIV Infection Proceedings of the ATS, December 1, 2005; 2(5): 423 - 427. [Abstract] [Full Text] [PDF]

				G. Barillari and B. Ensoli Angiogenic Effects of Extracellular Human Immunodeficiency Virus Type 1 Tat Protein and Its Role in the Pathogenesis of AIDS-Associated Kaposi's Sarcoma Clin. Microbiol. Rev., April 1, 2002; 15(2): 310 - 326. [Abstract] [Full Text] [PDF]

				D. Blond, H. Raoul, R. Le Grand, and D. Dormont Nitric Oxide Synthesis Enhances Human Immunodeficiency Virus Replication in Primary Human Macrophages J. Virol., October 1, 2000; 74(19): 8904 - 8912. [Abstract] [Full Text]

				I. Quinto, M. Mallardo, F. Baldassarre, G. Scala, G. Englund, and K.-T. Jeang Potent and Stable Attenuation of Live-HIV-1 by Gain of a Proteolysis-resistant Inhibitor of NF-kappa B (Ikappa B-alpha S32/36A) and the Implications for Vaccine Development J. Biol. Chem., June 18, 1999; 274(25): 17567 - 17572. [Abstract] [Full Text] [PDF]

				K. Murakami-Mori, S. Mori, and S. Nakamura Endogenous Basic Fibroblast Growth Factor Is Essential for Cyclin E-CDK2 Activity in Multiple External Cytokine-Induced Proliferation of AIDS-Associated Kaposi's Sarcoma Cells: Dual Control of AIDS-Associated Kaposi's Sarcoma Cell Growth and Cyclin E-CDK2 Activity by Endogenous and External Signals J. Immunol., August 15, 1998; 161(4): 1694 - 1704. [Abstract] [Full Text] [PDF]

				R. Esser, W. Glienke, R. Andreesen, R. E. Unger, M. Kreutz, H. Rubsamen-Waigmann, and H. von Briesen Individual Cell Analysis of the Cytokine Repertoire in Human Immunodeficiency Virus-1-Infected Monocytes/Macrophages by a Combination of Immunocytochemistry and In Situ Hybridization Blood, June 15, 1998; 91(12): 4752 - 4760. [Abstract] [Full Text] [PDF]

				D. K. Burns Topical Review Article: The Neuropathology of Pediatric Acquired Immunodeficiency Syndrome J Child Neurol, October 1, 1992; 7(4): 332 - 346. [Abstract] [PDF]